Key result
Implantable cardioverter-defibrillators are an effective treatment for preventing sudden cardiac arrhythmic death in Chagas disease, though high costs limit their widespread use in endemic regions.
ICDs are effective for preventing sudden cardiac death in Chagas disease, but their use is limited by cost in endemic regions.
Answers are grounded in this paper and cite their sources.
Supports targeted ICD use in high-risk Chagas cardiomyopathy; leaves open affordable access strategies in endemic regions.
Chagas’ disease remains a major epidemiologic problem in endemic countries. The most dramatic course of the disease is represented by sudden cardiac death. Some of these deaths could be preventable, if efforts are directed towards identifying high-risk patients. Implantable cardioverter-defibrillators are an effective treatment for the prevention of sudden cardiac arrhythmic death, however; its costs are the major limitation for their widespread use in the endemic region. This review will cover some of the most relevant aspects of sudden cardiac death in Chagas’ disease.
No takes yet. Share an insight, caveat, or question.
Toro et al. (2016) conducted a review in Chagas disease. Implantable cardioverter-defibrillators was evaluated on Sudden cardiac death. Implantable cardioverter-defibrillators are an effective treatment for preventing sudden cardiac arrhythmic death in Chagas disease, though high costs limit their widespread use in endemic regions.
Synapse has enriched 10 related papers. Consider them for comparative context: